We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Japanese drug company Astellas Pharma held on to its remaining Flomax patent last week when a federal district court said generic tamsulosin hydrochloride infringes on the patent for its enlarged-prostate treatment, according to a company representative.
Leading generic firm Teva Pharmaceutical will have partial marketing exclusivity privileges once it launches rabeprazole sodium, a generic version of Eisai’s acid-pump inhibitor drug, Aciphex.
The Prescription Access Litigation Project (PAL) has entered a $24 million settlement with EMD Serono and Merck Serono International to resolve a nationwide class-action lawsuit.
Sanofi-aventis has filed a patent infringement lawsuit in federal court to block the manufacturing and marketing of zolpidem tartrate, a generic version of its blockbuster sleep drug Ambien CR.
A federal court has ruled against sanofi-aventis in its patent infringement suit against Amphastar and Teva, paving the way for the FDA to review generic versions of the anticoagulant drug Lovenox.
Eli Lilly won a federal court injunction Feb. 13 requiring the return of documents on its marketing practices for Zyprexa, an antipsychotic drug used to treat bipolar disorder and schizophrenia.
The judge overseeing the Center for Reproductive Rights’ (CRR) lawsuit against the FDA granted the center’s request for discovery of additional agency documents, but put a stay on documents the group sought from the White House.
The judge overseeing the Center for Reproductive Rights’ (CRR) lawsuit against the FDA granted the center’s request for discovery of additional agency documents, but put a stay on documents the group sought from the White House.